COMMUNITY HEALTH SYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that COMMUNITY HEALTH SYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.49B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $12.63B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $12.49B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $12.21B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $12.37B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $11.79B | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $3.29B | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $3.25B | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $3.30B | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $3.38B | Feb 20, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $509.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($516.00M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | ($133.00M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $46.00M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $230.00M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $511.00M | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | ($373.00M) | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | ($17.00M) | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | ($167.00M) | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | ($118.00M) | Feb 20, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.49B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $542.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $957.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $821.00M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $1.40B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.13B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $650.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $208.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | ($1.88B) | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | ($860.00M) | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $543.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $480.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $210.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $300.00M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($131.00M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $2.18B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $385.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $274.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $773.00M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.14B | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $335.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $360.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $467.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $415.00M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $469.00M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $440.00M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $438.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $527.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $564.00M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $744.00M | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.20B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $14.05B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $14.46B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $14.67B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $15.22B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $16.01B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $15.61B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $15.86B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $17.45B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $21.94B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.04B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $15.37B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $15.28B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $15.40B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $16.03B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $17.06B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $17.25B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $16.82B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $17.62B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $19.66B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.39B) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($1.91B) | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | ($1.39B) | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | ($1.37B) | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | ($1.37B) | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | ($1.63B) | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | ($2.22B) | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | ($1.54B) | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | ($767.00M) | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $1.62B | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.32B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $3.79B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $3.96B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $4.17B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $4.22B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $4.22B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $4.33B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $4.56B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $4.72B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $6.52B | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.57B) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($4.08B) | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | ($3.56B) | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | ($3.43B) | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | ($3.48B) | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | ($3.71B) | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | ($4.22B) | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | ($3.54B) | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | ($2.76B) | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | ($299.00M) | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $260.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $37.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $38.00M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $118.00M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $507.00M | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.68B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $216.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $196.00M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $563.00M | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $238.00M | Feb 21, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.40B | Feb 19, 2026 |
| FY2024 | Dec 31, 2024 | $11.45B | Feb 19, 2025 |
| FY2023 | Dec 31, 2023 | $11.49B | Feb 21, 2024 |
| FY2022 | Dec 31, 2022 | $11.64B | Feb 17, 2023 |
| FY2021 | Dec 31, 2021 | $12.14B | Feb 17, 2022 |
| FY2020 | Dec 31, 2020 | $12.22B | Feb 18, 2021 |
| FY2019 | Dec 31, 2019 | $13.41B | Feb 20, 2020 |
| FY2018 | Dec 31, 2018 | $13.60B | Feb 21, 2019 |
| FY2017 | Dec 31, 2017 | $13.91B | Feb 28, 2018 |
| FY2016 | Dec 31, 2016 | $15.24B | Feb 21, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 4 | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | (3) | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | (1) | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | (1) | Feb 20, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 4 | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | (3) | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | (1) | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | (1) | Feb 20, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 138.63M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 138.92M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 136.77M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 134.70M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 132.15M | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | 129.61M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | 117.82M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | 116.25M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | 114.65M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | 113.88M | Feb 28, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2012 | $22.54M | Feb 26, 2014 |